Scarica l'app Stockscreener
86.46
1.48%
1.26
Dopo l'orario di chiusura:
86.93
0.47
+0.54%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$85.20
Aprire:
$85.25
Volume 24 ore:
10.43M
Relative Volume:
1.40
Capitalizzazione di mercato:
$110.58B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
37.97
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
-3.00%
1M Prestazione:
-11.08%
6M Prestazione:
+17.65%
1 anno Prestazione:
+11.63%
Intervallo 1D:
$85.25
$87.15
Intervallo di 1 settimana:
$84.23
$90.02
Portata 52W:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
86.46 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
371.90 | 327.80B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
386.43 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
270.53 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
388.36 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Cardinal Health rises on extended CVS distribution deal - Investing.com
One profession with endless impact: Celebrating pharmacists - CVS Health
McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health - marketscreener.com
McKesson (MCK) and Cardinal Health Extend CVS Health Distributio - GuruFocus
McKesson extends CVS deal; shares rise - Investing.com
Why Is Cardinal Health and McKesson Stock Trading Higher TodayCVS Health (NYSE:CVS), McKesson (NYSE:MC - Benzinga
Cardinal Health renews contract with CVS Health - marketscreener.com
CVS Health stock costs EUR 76.14 as revenue grew 7.30 percent - AD HOC NEWS
CVS Health Corporation (NYSE:CVS) Declares Quarterly Dividend of $0.67 - MarketBeat
Cantor Fitzgerald reiterates CVS Health stock rating on MA margins - Investing.com India
UnitedHealthcare, Aetna say 2027 Medicare Advantage plans to offer more limited provider networks - Yahoo Finance
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health - Yahoo Finance
CVS Health stock pre-market at EUR 75.75: plus 0.12 percent - AD HOC NEWS
CVS Health declares quarterly dividend of $0.665 per share - Investing.com
Cvs Health Declares Quarterly Dividend, Payable on November 2, 2026 - marketscreener.com
CVS Health (CVS) Declares Quarterly Dividend of $0.665 Per Share - GuruFocus
CVS Health Keeps Quarterly Dividend at $0.665 cents Per Share; Payable Nov. 2 to Shareholders of Record on Oct. 22 - marketscreener.com
A 66.5-cent CVS Health dividend is due Nov. 2. - Stock Titan
Prior authorization, reimagined: How CVS Caremark improves access to treatment - CVS Health
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace? - Zacks Investment Research
CVS Health stock trades at EUR 76.94 with plus 0.18 percent - AD HOC NEWS
Hunger Action Month: Supporting healthier communities through better access to nutritious food - CVS Health
MiraSOFT™ Launch at CVS Pharmacy, Expanding the MIRA Portfolio with a Stool Softener Option - Yahoo Finance
CVS Health: Value-Based Care Is Hard, but It's Worth Getting Right - FinanzNachrichten.de
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
Ask a CVS Pharmacist: Your top flu shot questions, answered - CVS Health
CVS Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health CorporationCVS - Business Wire
CVS Health Is Making a Difference in Local Communities, One Classroom at a Time - Yahoo Finance
CVS Health stock at USD 89.13 on September 25, 2026 - AD HOC NEWS
CVS Health Corp (CVS) Shares Surge 4.8% -- What GF Score of 81 T - GuruFocus
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Why is CVS Health stock rallying today? - Investing.com
Why is CVS Health stock rallying today? By Investing.com - Investing.com Canada
CVS rises as investors revisit stronger guidance and fading Omnicare overhang - Quiver Quantitative
CVS Health Corp Stock (CVS) Moved Up by 3.65% on Sep 25: What Signal Does It Send? - TradingKey
CVS Health stock trades at USD 85.21 as Q2 revenue rises 7.3 percent - AD HOC NEWS
CVS Health Strengthens Energy Resilience To Support Patient Care - ACCESS Newswire
CVS Health stock heads into the open after an 1.2 percent drop - ad-hoc-news.de
CVS Looks 7.6% Overvalued on GF Value™ as Dividend Sustainabilit - GuruFocus
What Should CVS Stock Investors Be Watching Now? - Yahoo Finance
After 30 years, a Hepatitis C treatment that finally worked - CVS Health
Aetna expands cancer treatment prior authorization bundles - Investing.com
CVS Health; Criteo Agree to Pay Combined $20.5 Million to Resolve Website Tracking Litigation - The HIPAA Journal
Aetna Expands Bundled Oncology Prior Authorizations, Easing Provider Burden and Accelerating Member Access to Care - finance.yahoo.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CVS online shoppers could get cash from $20.5M settlement - The Clarion-Ledger
QRG Capital Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Envestnet Asset Management Inc. Boosts Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health stock slips 1.4 percent ahead of the open - AD HOC NEWS
CVS Health stock falls 2.93 percent at the close - AD HOC NEWS
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):